US-based healthcare data technology provider Ciox Health has raised $30m in a funding round co-led by pharmaceutical firm Merck & Co’s Global Health Innovation (GHI) Fund and investment firm New Mountain Capital.
Founded in 1976, Ciox Health has developed an artificial intelligence-powered platform that is used to extract and access data from disparate health records.
The technology is used by healthcare providers, law firms, life science companies, life insurers and patients to track, view, download, store and verify the status of medical record requests.
Ciox will use the capital to accelerate the development of its health data repository, Digital Patient Clone, as well as to strengthen partnerships with healthcare providers to advance clinical research and development.
David Rubin, managing director at Merck Global Health Innovation Fund, said: “We are pleased to partner with Ciox, a leader in moving data and information among provider systems, patients and clients.
“Ciox brings a unique approach to accessing real world data at scale, and we expect them to partner intimately with companies within the GHI oncology digital health portfolio. Ultimately, Ciox’s technology will advance clinical research and accelerate the launch of new treatments.”